P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

• Wojciech Jurczak,
• Herve Ghesquieres,
• Yasmin Karimi,
• Chan Cheah,
• Michael Roost Clausen,
• David Cunningham,
• Young Rok Do,
• David Lewis,
• Robin Gasiorowski,
• Tae Min Kim,
• Marjolein Van Der Poel,
• Michelle Limei Poon,
• Tatyana Feldman,
• Kim Linton,
• Anna Sureda,
• Martin Hutchings,
• Salim Kanoun,
• Laetitia Vercellino,
• Mariana Cota Stirner,
• Stephanie Mcgoldrick,
• Yan Liu,
• Mariana Sacchi,
• Pieternella Lugtenburg,
• Catherine Thieblemont

Affiliations

Wojciech Jurczak

1 MSC National Research Institute of Oncology, Kraków, Poland,

Herve Ghesquieres

2 Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France,

Yasmin Karimi

3 University of Michigan Comprehensive Cancer Center,, Ann Arbor, United States,

Chan Cheah

4 Sir Charles Gairdner Hospital, Nedlands, Australia,

Michael Roost Clausen

5 Vejle Hospital, Vejle, Denmark,

David Cunningham

6 The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom,

Young Rok Do

7 Keimyung University Dongsan Medical Center, Daegu, Korea, Rep. of South,

David Lewis

8 University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth, United Kingdom,

Robin Gasiorowski

9 Concord Hospital, University of Sydney, Sydney, Australia,

Tae Min Kim

10 Seoul National University Hospital, Seoul, Korea, Rep. of South,

Marjolein Van Der Poel

11 On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Maastricht, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands,

Michelle Limei Poon

12 National University Hospital, Singapore, Singapore,

Tatyana Feldman

13 Hackensack Meridian Health Hackensack University Medical Center, Hackensack, United States,

Kim Linton

14 The Christie NHS Foundation Trust and Manchester Cancer Research Centre, Manchester, United Kingdom,

Anna Sureda

15 Institut Català d’Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain,

Martin Hutchings

16 Rigshospitalet, Copenhagen University Hospital,, Copenhagen, Denmark,

Salim Kanoun

17 Cancer Research Center of Toulouse, Toulouse, France,

Laetitia Vercellino

18 Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Médecine Nucléaire, Université de Paris, Paris, France,

Mariana Cota Stirner

19 AbbVie, North Chicago, United States,

Stephanie Mcgoldrick

20 Genmab, Princeton, United States,

Yan Liu

20 Genmab, Princeton, United States,

Mariana Sacchi

20 Genmab, Princeton, United States,

Pieternella Lugtenburg

21 On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, The Netherlands,

Catherine Thieblemont

22 Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France